Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies von Powell, C.A., Modi, S., Iwata, H., Takahashi, S., Smit, E.F., Siena, S., Chang, D.-Y., Macpherson, E., Qin, A., Singh, J., Taitt, C., Shire, N., Camidge, D. Ross

Volltext

ADRIATIC: A phase III trial of durvalumab ± tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer von Senan, S., Shire, N., Mak, G., Yao, W., Jiang, H.

Volltext

Match-adjusted indirect comparison of durvalumab and chemotherapy for locally advanced or metastatic urothelial carcinoma (UC) following failure of platinum-based therapy von Hoyle, C.K., Klein, A.B., Patel, K.A., Shire, N., Wang, H., Chu, B.C., Ouwens, M., Nordstrom, B.L., Horne, L., Arkenau, H.-T.

Volltext

Response rates to pegylated interferon and ribavirin in HCV/HIV coinfection: a research synthesis von Shire, N. J., Welge, J. A., Sherman, K. E.

Volltext

Characterization of hepatitis E-specific cell-mediated immune response using IFN-γ ELISPOT assay von Shata, M.T., Barrett, A., Shire, N.J., Abdelwahab, S.F., Sobhy, M., Daef, E., El-Kamary, S.S., Hashem, M., Engle, R.E., Purcell, R.H., Emerson, S.U., Strickland, G.T., Sherman, K.E.

Volltext

Occult hepatitis B in HIV-infected patients von SHIRE, Norah J, ROUSTER, Susan D, RAJICIC, Natasa, SHERMAN, Kenneth E

Volltext

Gene expression analysis in serial liver fine needle aspirates von Lejnine, S., Marton, M. J., Wang, I.-M., Howell, B. J., Webber, A. L., Maxwell, J. W., Shire, N., Malkov, V., Lunceford, J., Zeremski, M., Sun, A., Ruddy, M., Talal, A. H.

Volltext

Liver Injury and Changes in Hepatitis C Virus (HCV) RNA Load Associated with Protease Inhibitor–Based Antiretroviral Therapy for Treatment-Naive HCV-HIV–Coinfected Patients: Lopina... von Sherman, Kenneth E., Shire, Norah J., Cernohous, Paul, Rouster, Susan D., Omachi, Janice H., Brun, Scott, Silva, Barbara Da

Volltext

1100 DIRECT INHIBITION OF NS3/4A WITH BOCEPREVIR DOES NOT INCREASE INDUCTION OF ISG: AN ANALYSIS OF THE PIVOTAL BOCEPREVIR TRIALS (SPRINT-2/RESPOND-2) von Molony, C, Cristescu, R, Shaw, P, Shire, N, Wahl, J, Brass, C, Cooreman, M

Volltext

Genomic variability associated with the presence of occult hepatitis B virus in HIV co-infected individuals von Martin, C. M., Welge, J. A., Shire, N. J., Rouster, S. D., Shata, M. T., Sherman, K. E., Blackard, J. T.

Volltext

Heat Transfer in Flow Boiling Over a Bundle of Horizontal Tubes von Burnside, B.M., Shire, N.F.

Volltext

67TiPADRIATIC: A phase III trial of durvalumab ± tremelimumab after concurrent chemoradiation for patients with limited stage small cell lung cancer von Senan, S, Shire, N, Mak, G, Yao, W, Jiang, H

Volltext

Human Immunodeficiency Virus-Infected Patients with Prior Pneumocystis Pneumonia Exhibit Increased Serologic Reactivity to Several Major Surface Glycoprotein Clones von Daly, K R, Koch, J V, Shire, N J, Levin, L, Walzer, P D

Volltext

OA07.02 LKB1 Mutations in Metastatic Non-Small Cell Lung Cancer (mNSCLC): Prognostic Value in the Real World von Golozar, A., Collins, J., Fraeman, K., Nordstrom, B., Mcewen, R., Shire, N., Higgs, B.

Volltext

Topical testosterone treatment for chronic allograft failure in liver transplant recipients with recurrent hepatitis C virus von Neff, G.W., O'Brien, C.B., Shire, N.J., DeManno, A., Kahn, S., Rideman, E., Safdar, K., Madariaga, J., Rudich, S.R.

Volltext

EP08.01-042 NEPTUNE China Cohort: First-Line Durvalumab + Tremelimumab versus Chemotherapy in Chinese Patients with Metastatic NSCLC von Cheng, Y., Zhou, Q., Han, B., Fan, Y., Shan, L., Chang, J., Sun, S., Fang, J., Chen, Y., Sun, J., Wu, G., Mann, H., Naicker, K., Shire, N., Mok, T., de Castro, G.

Volltext

Clinical Trials of Treatment for Hepatitis C Virus Infection in HIV-Infected Patients: Past, Present, and Future von Shire, Norah J., Sherman, Kenneth E.

Volltext

PCN264 - ASSESSMENT OF TREATMENTS AND HEALTH CARE UTILISATION (HCU) IN SPAIN FOLLOWING INITIAL PLATINUM THERAPY FOR RECURRENT OR METASTATIC (R/M) HEAD AND NECK SQUAMOUS CELL CARCIN... von Parikh, R.C., Kurosky, S., Kaye, J.A., Levine, C., Hettle, R., Shire, N., Sawyer, W., Wang, H.

Volltext

PCN268 - TREATMENTS AND HEALTH CARE UTILISATION (HCU) IN PATIENTS WITH RECURRENT OR METASTATIC (R/M) HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC) FOLLOWING INITIAL PLATINUM THERAP... von Parikh, R.C., Kurosky, S., Kaye, J.A., Levine, C., Hettle, R., Shire, N., Mann, H., Wang, H.

Volltext

PCN257 - TREATMENTS AND HEALTH CARE UTILISATION (HCU) FOLLOWING INITIAL PLATINUM THERAPY IN PATIENTS WITH RECURRENT OR METASTATIC (R/M) HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC... von Parikh, R.C., Kurosky, S., Kaye, J.A., Levine, C., Hettle, R., Shire, N., Sawyer, W., Wang, H.

Volltext